Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1991 2
1993 2
1995 1
1996 1
1999 1
2000 4
2001 3
2002 3
2003 6
2004 8
2005 10
2006 12
2007 12
2008 9
2009 13
2010 7
2011 5
2012 4
2013 3
2014 3
2015 2
2017 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Results by year
Filters applied: . Clear all
Page 1
Antimicrobial polymers.
Ackart WB, Camp RL, Wheelwright WL, Byck JS. Ackart WB, et al. Among authors: camp rl. J Biomed Mater Res. 1975 Jan;9(1):55-68. doi: 10.1002/jbm.820090106. J Biomed Mater Res. 1975. PMID: 809445
Automated analysis of tissue microarrays.
Dolled-Filhart M, Gustavson M, Camp RL, Rimm DL, Tonkinson JL, Christiansen J. Dolled-Filhart M, et al. Among authors: camp rl. Methods Mol Biol. 2010;664:151-62. doi: 10.1007/978-1-60761-806-5_15. Methods Mol Biol. 2010. PMID: 20690061
CD70 expression patterns in renal cell carcinoma.
Jilaveanu LB, Sznol J, Aziz SA, Duchen D, Kluger HM, Camp RL. Jilaveanu LB, et al. Among authors: camp rl. Hum Pathol. 2012 Sep;43(9):1394-9. doi: 10.1016/j.humpath.2011.10.014. Epub 2012 Mar 7. Hum Pathol. 2012. PMID: 22401771 Free PMC article.
In vitro studies of dasatinib, its targets and predictors of sensitivity.
Jilaveanu LB, Zito CR, Aziz SA, Chakraborty A, Davies MA, Camp RL, Rimm DL, Dudek A, Sznol M, Kluger HM. Jilaveanu LB, et al. Among authors: camp rl. Pigment Cell Melanoma Res. 2011 Apr;24(2):386-9. doi: 10.1111/j.1755-148X.2011.00835.x. Pigment Cell Melanoma Res. 2011. PMID: 21320292 Free PMC article. No abstract available.
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.
Jilaveanu LB, Puligandla M, Weiss SA, Wang XV, Zito C, Flaherty KT, Boeke M, Neumeister V, Camp RL, Adeniran A, Pins M, Manola J, DiPaola RS, Haas NB, Kluger HM. Jilaveanu LB, et al. Among authors: camp rl. Clin Cancer Res. 2018 Jan 1;24(1):217-223. doi: 10.1158/1078-0432.CCR-17-1555. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066509 Free PMC article. Clinical Trial.
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
Aziz SA, Davies M, Pick E, Zito C, Jilaveanu L, Camp RL, Rimm DL, Kluger Y, Kluger HM. Aziz SA, et al. Among authors: camp rl. Clin Cancer Res. 2009 May 1;15(9):3029-36. doi: 10.1158/1078-0432.CCR-08-2768. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383818 Free PMC article.
HSP90 as a marker of progression in melanoma.
McCarthy MM, Pick E, Kluger Y, Gould-Rothberg B, Lazova R, Camp RL, Rimm DL, Kluger HM. McCarthy MM, et al. Among authors: camp rl. Ann Oncol. 2008 Mar;19(3):590-4. doi: 10.1093/annonc/mdm545. Epub 2007 Nov 23. Ann Oncol. 2008. PMID: 18037622 Free article.
104 results